Drugs and Pacemakers in Patients with Atrial Fibrillation and Heart Failure
Atrial fibrillation (AF) is a common arrhythmia: its incidence increases markedly with age and it is frequently associated with heart failure (HF) . In patients with HF the incidence of AF is estimated at between 20% and 40%.HF gives rise to electrophysiologic and hemodynamic changes in atrial tissue that favor the onset and maintenance of atrial fibrillation: sympathetic tone, increased pressure, wall-stretching, and mitral regurgitation. On the other hand, the onset of AF in patients with HF often leads to a marked worsening of the clinical condition of these patients: loss of atrial systole, high and irregular ventricular rate, mitral regurgitation, low coronary and cerebral flow, and so on.
KeywordsAtrial Fibrillation Mitral Regurgitation Heart Failure Patient Rhythm Control Atrial Tissue
Unable to display preview. Download preview PDF.
- 3.Clemo HF, Wood MA, Gilligan DM et al (1998) Intravenous amiodarone for acute heart rate in critically ill patients with atrial tachyarrhythmias. Am J Cardiol 81:594598Google Scholar
- 6.Padeletti L, Porcioni C, Michelucci A et al (1999) Long-term efficacy in prevention of paroximal atrial fibrillation (abstract). Pacing Clin Electrophysiol 22:A14Google Scholar
- 8.Boriani G, Biffi M, Padeletti L et al (1999) Consistent atrial pacing (CAP) and atrial rate stabilization (ARS): new algorithm to suppress recurrent atrial fibrillation. G Ital Cardiol 29 [Suppl 51:88–90Google Scholar
- 9.A new stimulation algorithm for suppression of atrial fibrillation: dynamic atria overdrive (DAO) (2000) DEVICE 4:1Google Scholar